Geodon and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Geodon (ziprasidone hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Depakote, and have Psychotic disorder.

The phase IV clinical study analyzes which people have Hyperventilation when taking Geodon. It is created by eHealthMe based on reports of 18,215 people who have side effects when taking Geodon from the FDA, and is updated regularly.

What is Geodon?

Geodon has active ingredients of ziprasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 19,504 Geodon users. Check the latest studies of Geodon.

What is Hyperventilation?

Hyperventilation is found to be associated with 782 drugs and 1,444 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Feb, 24, 2026

18,215 people reported to have side effects when taking Geodon.
Among them, 23 people (0.13%) have Hyperventilation.

Among these 23 people:

How long have people been on Geodon when they have Hyperventilation? *

What is the gender of people who have Hyperventilation when taking Geodon? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Hyperventilation when taking Geodon? *

What are other drugs people take besides Geodon? *

What are other side effects people have besides Hyperventilation? *

Drowsiness: 13 people, 56.52%
Fatigue (feeling of tiredness): 11 people, 47.83%
Confusional State: 10 people, 43.48%
Arrhythmias (irregular heartbeat): 10 people, 43.48%
Weight Increased: 10 people, 43.48%
Urticaria (rash of round, red welts on the skin that itch intensely): 9 people, 39.13%
Constipation: 9 people, 39.13%
Chest Pain: 9 people, 39.13%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 9 people, 39.13%
Blood Creatine Phosphokinase Increased: 9 people, 39.13%

What are the existing conditions these people have? *

Psychotic Disorder: 6 people, 26.09%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 13.04%
Affective Disorder (mental disorder): 3 people, 13.04%
Insomnia (sleeplessness): 2 people, 8.70%
Stress And Anxiety: 1 person, 4.35%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 4.35%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 4.35%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.35%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 4.35%
Agitation (state of anxiety or nervous excitement): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Geodon and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Geodon:

Geodon (19,504 reports)

Browse all side effects of Geodon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (782 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,444 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ziprasidone hydrochloride (the active ingredients of Geodon) and Geodon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.